Advertisement
Co Presented By
Co Presented By

Cognizant To Buy marketRx For $135 Mn

This acquisition strengthens Cognizant's full-suite of offerings across all areas of the life sciences value chain.

Advertisement
FP Archives|Jan 31, 2017, 01:20:12 IST

Cognizant Technology Solutions has signed a definitive agreement to acquire the US-based marketRx for $135 million.

This acquisition strengthens Cognizant's full-suite of offerings across all areas of the life sciences value chain-from research and development and manufacturing to sales and marketing operations, the company said in a statement.

"This acquisition expands our capabilities in the analytics segment and broadens our service offerings for the life sciences industry, while providing strong synergies with our existing business intelligence/data warehousing and customer relationship management services," said Francisco D'Souza, president and CEO, Cognizant.

Advertisement

marketRx, based in New Jersey, is engaged in analytics and related software services to pharmaceutical, biotechnology and medical devices companies.

IANS

Handpicked stories, in your inbox
Global stories. Indian perspective. Zero noise.
No Spam. Unsubscribe Any Time.
First Published:Oct 19, 2007, 15:17:56 IST
Advertisement
Advertisement
Advertisement
Advertisement
Up Next